Results 11 to 20 of about 1,440,519 (266)

The Impact on Systematic Reviews of Risk of Bias Assessment Changes From Conference Abstracts to Full Text [PDF]

Cochrane Evidence Synthesis and Methods
Conference abstracts are commonly included in systematic reviews of evidence. Due to limitations in word count, conference abstracts often lack data or information. This causes issues for the assessment of risk of bias (RoB).
Ryan P. W. Kenny, Katie Twentyman, Dawn Craig, Nick Meader, Gill Norman   +4 more
doaj   +2 more sources

Human Versus Artificial Intelligence: Comparing Cochrane Authors' and ChatGPT's Risk of Bias Assessments [PDF]

Cochrane Evidence Synthesis and Methods
Introduction Systematic reviews and meta‐analyses synthesize randomized trial data to guide clinical decisions but require significant time and resources.
Petek Eylul Taneri
doaj   +2 more sources

Change over Five Years in Important Measures of Methodological Quality and Reporting in Randomized Cardiovascular Clinical Trials

Journal of Cardiovascular Development and Disease, 2023
Objectives: The aim of our current study was to analyze whether the use of important measures of methodological quality and reporting of randomized clinical trials published in the field of cardiovascular disease research haschanged over time.
Odgerel Baasan, Omar Freihat, Dávid U. Nagy, Szimonetta Lohner   +3 more
doaj   +1 more source

Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains

BMC Medical Research Methodology, 2021
Background Initially, the Cochrane risk of bias (RoB) tool had a domain for “blinding of participants, personnel and outcome assessors”. In the 2011 tool, the assessment of blinding was split into two domains: blinding of participants and personnel ...
Ognjen Barcot, Matija Boric, Svjetlana Dosenovic, Livia Puljak   +3 more
doaj   +1 more source

Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review

Current Oncology, 2021
Aim: The aim of this study was to systematically assess the risk of bias in osteosarcoma and Ewing’s sarcoma (ES) randomized controlled trials (RCT) and to examine the relationships between bias and conflict of interest/industry sponsorship.
Robert Koucheki, Aaron M. Gazendam, Jonathan R. Perera, Anthony Griffin, Peter Ferguson, Jay Wunder, Kim Tsoi   +6 more
doaj   +1 more source

What tool do undergraduate pharmacy students prefer when grading systematic review evidence: AMSTAR‐2 or ROBIS?

Cochrane Evidence Synthesis and Methods, 2023
Introduction While systematic reviews (SRs) are considered the highest form of evidence in the hierarchy, the quality and standard of reviews varies. Two quality assessment tools have been developed to assess the variation in such standards.
Shaun W. H. Lee
doaj   +1 more source

Methodological Quality and Risk of Bias Assessment of Cardiovascular Disease Research: Analysis of Randomized Controlled Trials Published in 2017

Frontiers in Cardiovascular Medicine, 2022
BackgroundAll randomized-controlled trials (RCTs) are required to follow high methodological standards. In this study, we aimed to assess the methodological quality of published cardiovascular clinical research trials in a representative sample of RCTs ...
Odgerel Baasan, Odgerel Baasan, Omar Freihat, David U. Nagy, David U. Nagy, Szimonetta Lohner, Szimonetta Lohner   +6 more
doaj   +1 more source

5G New Radio Requires the Best Possible Risk Assessment Studies: Perspective and Recommended Guidelines

Frontiers in Communications and Networks, 2021
The development and establishment of mobile communication technologies has necessitated assessments of possible risks to human health from exposures to radio-frequency electromagnetic fields (RF EMF).
Mats-Olof Mattsson, Mats-Olof Mattsson, Myrtill Simkó, Myrtill Simkó, Kenneth R. Foster   +4 more
doaj   +1 more source

Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials

Frontiers in Pharmacology, 2023
Introduction: Chronic fatigue syndrome (CFS) is an increasingly common condition that is challenging to treat due to unclear etiology and a lack of consensus on clinical diagnosis and treatment guidance. Many affected people resorted to using traditional
Yuxiao Li, Jingya Yang, Chi Ian Chau, Junnan Shi, Xianwen Chen, Hao Hu, Hao Hu, Carolina Oi Lam Ung, Carolina Oi Lam Ung   +8 more
doaj   +1 more source

Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background A cointervention in a randomized clinical trial (RCT) is medical care given in addition to the tested intervention. If cointerventions are unbalanced between trial arms, the results may be biased.
Elisavet Moutzouri, Luise Adam, Martin Feller, Lamprini Syrogiannouli, Bruno R. Da Costa, Cinzia Del Giovane, Douglas C. Bauer, Drahomir Aujesky, Arnaud Chiolero, Nicolas Rodondi   +9 more
doaj   +1 more source